InvestSMART

Next Science Limited (ASX: NXS) - Announcements

DELISTED - Current share price for NXS : $0.145

ASX company news and announcements for Next Science Limited (NXS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Next Science Limited (NXS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Next Science Limited (NXS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Next Science Limited (NXS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Next Science's XPERIENCE product cleared for sale in Canada 26 Aug 2022 9:33AM $0.895 $0.145 fallen by 83.80%
- Half Year Results Investor Presentation 25 Aug 2022 8:41AM $0.895 $0.145 fallen by 83.80%
- Half Year Report & Appendix 4D 25 Aug 2022 8:03AM $0.895 $0.145 fallen by 83.80%
- Half Year Results Investor Briefing 11 Aug 2022 3:32PM $0.940 $0.145 fallen by 84.57%
- Investor Presentation - Q2 2022 25 Jul 2022 4:37PM $0.800 $0.145 fallen by 81.88%
- Quarterly Activity Report - 30 June 2022 25 Jul 2022 4:28PM $0.800 $0.145 fallen by 81.88%
- Appendix 4C - 30 June 2022 25 Jul 2022 4:21PM $0.800 $0.145 fallen by 81.88%
- Change in substantial holding 4 Jul 2022 1:47PM $0.850 $0.145 fallen by 82.94%
- Cleansing notice 3 Jun 2022 9:45AM $0.740 $0.145 fallen by 80.41%
- Application for quotation of securities - NXS 1 Jun 2022 3:15PM $0.790 $0.145 fallen by 81.65%
- 2022 AGM - Voting Results 27 May 2022 12:51PM $0.820 $0.145 fallen by 82.32%
- AGM Chair & Managing Director Addresses 27 May 2022 9:25AM $0.845 $0.145 fallen by 82.84%
- Next Science to strengthen senior leadership presence in US 27 May 2022 9:17AM $0.845 $0.145 fallen by 82.84%
- Oraderm Pharmaceuticals appointed as BlastX distributor 19 May 2022 11:39AM $0.820 $0.145 fallen by 82.32%
- Investor Presentation - Q1 2022 28 Apr 2022 8:31AM $0.845 $0.145 fallen by 82.84%
- Appendix 4C - 31 March 2022 28 Apr 2022 8:20AM $0.845 $0.145 fallen by 82.84%
- Quarterly Activity Report - 31 March 2022 28 Apr 2022 8:20AM $0.845 $0.145 fallen by 82.84%
- 2022 Corporate Governance Statement & Appendix 4G 22 Apr 2022 10:35AM $0.825 $0.145 fallen by 82.42%
- 2021 Annual Report 22 Apr 2022 9:28AM $0.825 $0.145 fallen by 82.42%
- Next Science 2022 AGM 22 Apr 2022 9:20AM $0.825 $0.145 fallen by 82.42%
- Appendix 3Y - Judith Mitchell 31 Mar 2022 4:36PM $0.890 $0.145 fallen by 83.71%
- Appendix 3Y - B Hancox 29 Mar 2022 2:52PM $0.885 $0.145 fallen by 83.62%
- Appendix 3Y - D Spira 29 Mar 2022 2:51PM $0.885 $0.145 fallen by 83.62%
- Appendix 3Y - M Compton 29 Mar 2022 2:51PM $0.885 $0.145 fallen by 83.62%
- Application for quotation of securities - NXS 28 Mar 2022 8:42AM $0.865 $0.145 fallen by 83.24%

201 - 225 of 748 results

Page 9 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.